Clinical Trial Update: Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Vitagel to reduce blood loss and pain after unilateral total knee arthroplasty; study completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis

Drugs mentioned

• Vitagel

Snippet

Sponsor: The Cleveland Clinic | Conditions: Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2012-11-29